Literature DB >> 25226296

RASAL1 in thyroid cancer: promise from a new friend.

Mingzhao Xing1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25226296      PMCID： PMC4184083          DOI： 10.1210/jc.2014-2645

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  13 in total

Review 1.  Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 2.  Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.

Authors:  Sebastian Laycock-van Spyk; Nick Thomas; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

3.  Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.

Authors:  Peng Hou; Dingxie Liu; Yuan Shan; Shuiying Hu; Kimberley Studeman; Stephen Condouris; Yangang Wang; Ariel Trink; Adel K El-Naggar; Giovanni Tallini; Vasily Vasko; Mingzhao Xing
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

Review 4.  Molecular pathogenesis and mechanisms of thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

Review 5.  Cowden syndrome.

Authors:  Shanna Gustafson; Kevin M Zbuk; Cheryl Scacheri; Charis Eng
Journal:  Semin Oncol       Date:  2007-10       Impact factor: 4.929

6.  Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population.

Authors:  Jehad Abubaker; Zeenath Jehan; Prashant Bavi; Mehar Sultana; Sayer Al-Harbi; Muna Ibrahim; Abdulrahman Al-Nuaim; Mohammed Ahmed; Tarek Amin; Maha Al-Fehaily; Osama Al-Sanea; Fouad Al-Dayel; Shahab Uddin; Khawla S Al-Kuraya
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

7.  Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.

Authors:  Zhi Liu; Peng Hou; Meiju Ji; Haixia Guan; Kimberly Studeman; Kirk Jensen; Vasily Vasko; Adel K El-Naggar; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

Review 8.  Neurofibromatosis type 1 and associated malignancies.

Authors:  Kaleb Yohay
Journal:  Curr Neurol Neurosci Rep       Date:  2009-05       Impact factor: 5.081

9.  Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors.

Authors:  Peng Hou; Meiju Ji; Mingzhao Xing
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

10.  High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors.

Authors:  Yangang Wang; Peng Hou; Hongyu Yu; Wei Wang; Meiju Ji; Shihua Zhao; Shengli Yan; Xianlu Sun; Dingxie Liu; Bingyin Shi; Guangwu Zhu; Stephen Condouris; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2007-04-10       Impact factor: 5.958
View more
  2 in total

Review 1.  Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View.

Authors:  Sadegh Rajabi; Catherine Alix-Panabières; Arshia Sharbatdar Alaei; Raziyeh Abooshahab; Heewa Shakib; Mohammad Reza Ashrafi
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

2.  RASAL3 Is a Putative RasGAP Modulating Inflammatory Response by Neutrophils.

Authors:  Suguru Saito; Duo-Yao Cao; Aaron R Victor; Zhenzi Peng; Hui-Ya Wu; Derick Okwan-Duodu
Journal:  Front Immunol       Date:  2021-10-27       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.